Primary Cutaneous Infection with Scedosporium apiospermum Successfully Treated with Intravenouse Itraconazole.
- Author:
Sooyeon KIM
1
;
Sangshin LEE
;
Young LEE
;
Youngjoon SEO
;
Jeunghoon LEE
;
Myung IM
Author Information
1. Department of Dermatology, School of Medicine, Chungnam National University, Daejeon, Korea. im1177@hanmail.net
- Publication Type:Case Report
- Keywords:
Itraconazole;
Scedosporium apiospermum
- MeSH:
Aged, 80 and over;
Dermis;
Fluconazole;
Forearm;
Fungi;
Humans;
Hyphae;
Itraconazole;
Male;
Methylmethacrylates;
Polystyrenes;
Prurigo;
Scedosporium;
Skin;
Spores
- From:Korean Journal of Medical Mycology
2011;16(3):105-108
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Scedosporium apiospermum is a rising opportunistic fungus that may infect immunocompetent individuals and may cause often fatal disease among the increasing immunosuppressed patient population. This pathogen is typically difficult to treat because of its particular resistance to commonly used antimycotic drugs. We describe an 83-year-old male patient with a history of long-term corticosteroid treatment for chronic prurigo simplex, who developed multiple suppurative nodules on a erythematous plaque at the right forearm. Histological examinations revealed granulomatous infiltration with hyphae and spores in dermis and fungal cultured isolation for definitive diagnosis showed S. apiospermum. Treatment was started with oral fluconazole, but skin lesions were getting worse. Then patient was treated with 200 mg of intravenouse itraconazole daily. Skin lesions showed a marked improvement after 1 week, and completely healing after 3 weeks.
